FDA
- Status: approved
Ornithine aspartate granule simulant (Ornithine aspartate granule simulant) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.